STOCKHOLM, SE / ACCESS Newswire / July 29, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing ...

Experts call for national diabetes guidelines to include routine testing for testosterone deficiency in men  New UK consensus paper urges action to improve testosterone deficiency (TD) diagnosis and ...

Half Year Report/Half Year ResultsDrägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years 29.07.2025 / 07:30 CET/CESTThe issuer is solely ...

NeuroX recently acquired the assets and operations of MindMaze, a world-renowned leader in evidence-based neurotherapeutic solutions for neurological diseases and brain disordersBusiness combination ...

VANCOUVER, BC / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company focused on developing therapeutics for rare and underserved ...

Biomaterials engineered to restore, replace, or augment damaged tissues are gaining momentum—and at the core are Regenerative ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. ("Lobe Sciences" ...

In recent years, the global health and wellness industry has seen an unprecedented evolution—not only in mainstream personal ...

The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of ...

Netsmart ranks as top EHR software in 2025's Top HIT Vendor for Inpatient Behavioral Health Systems WASHINGTON, D.C., WASHINGTON, D.C. / ACCESS Newswire / July 28, 2025 / Psychiatric hospitals and ...

This acquisition expands neurocare’s clinic network to 11 locations in the Netherlands and marks a key step into care focused on pregnancy, early parenthood, and family wellbeing. NIJMEGEN, ...

GOTHENBURG, SWEDEN / ACCESS Newswire / July 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have ...